Antiviral activity of 4-benzyl pyridinone derivatives as HIV-1 reverse transcriptase inhibitors

Author： Andreola Marie-Line Nguyen Chi Hung Ventura Michel Tarrago-Litvak Laura Legraverend Michel

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.6, Iss.2, 2001-10, pp. : 225-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of pharmacophore models for predicting HIV-1 reverse transcriptase inhibitory activity of pyridinone derivatives

By Rani P.

Pharmaceutical Chemistry Journal, Vol. 45, Iss. 1, 2011-04 ,pp. : 36-42

Springer Publishing Company

Access to resources Recommend Favorite

Topochemical Models for Prediction of Anti-HIV Activity of 4-Benzyl Pyridinone Derivatives

By Bajaj Sanjay Sambi S. Madan A. K.

Drug Development and Industrial Pharmacy, Vol. 31, Iss. 10, 2005-12 ,pp. : 1041-1051

Informa Healthcare

Access to resources Recommend Favorite

QSAR Study on Pyridinone Derivatives as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor: A Mixed Approach

Medicinal Chemistry, Vol. 3, Iss. 3, 2007-05 ,pp. : 227-232

Bentham Science Publishers

Access to resources Recommend Favorite

TSAO Derivatives, Inhibitors of HIV-1 Reverse Transcriptase Dimerization: Recent Progress

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1895-1907

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 reverse transcriptase inhibitors

By Krawczyk Sören Hilgeroth Andreas

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 270-276

Govi-Verlag

Access to resources Recommend Favorite